Although no parallels have been established between these processes in the lungs and arteries, the current understanding of the function of ABCA1 in the pathogenesis of COPD and atherosclerosis is based on the fact that reverse cholesterol transport not only provides cellular and extracellular cholesterol homeostasis but also participates in inflammation through several mechanisms. This evidence concerns the gene ABCA1 and chronic obstructive pulmonary disease.